BackWe Can Medicines , Ltd. Overview

We Can Medicines , Ltd. Other Current Liabilities

Latest other current liabilities for 6929.TWO: $140M.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$138.62M
↓ 8.90% YoYΔ $-13.54M vs prior year quarter

Peer trimmed avg / median

Loading

We Can Medicines , Ltd. Other Current Liabilities History

Loading

We Can Medicines , Ltd. vs. peers: Other Current Liabilities Comparison

Loading

We Can Medicines , Ltd. Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

We Can Medicines , Ltd. (6929.TWO) FAQ

As of the most recent data (June 2026), 6929.TWO shows a other current liabilities of $140M. That compares with $150M in the prior-year period — down 8.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 6929.TWO's other current liabilities is now $140M (was $150M) — a 8.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether We Can Medicines , Ltd. is outperforming or lagging.

Tracking 6929.TWO's other current liabilities over time shows whether We Can Medicines , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $140M That compares with $150M in the prior-year period — down 8.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has We Can Medicines , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $140M) with ownership activity and broader fundamentals.